Cathepsin D concentration in tumor cytosols improves the accuracy of prognostic evaluation of primary breast cancer

被引：0

作者：

Ardavanis, A

Scorilas, A

Amanatidou, A

Gerakini, F

Missitzis, I

Garoufali, A

Pissakas, G

Pateras, C

Apostolikas, N

Rigatos, G

Yiotis, I

机构：

[1] ST SAVVAS CANC HOSP,HORMONAL RECEPTORS LAB,ATHENS 11522,GREECE

[2] ST SAVVAS CANC HOSP,BREAST CLIN,ATHENS 11522,GREECE

[3] ST SAVVAS CANC HOSP,RADIOTHERAPY DEPT 2,ATHENS 11522,GREECE

[4] ST SAVVAS CANC HOSP,PATHOL LAB,ATHENS 11522,GREECE

来源：

ANTICANCER RESEARCH | 1997年 / 17卷 / 2B期

关键词：

breast cancer; prognostic factors; cathepsin D;

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

One hundred and seventy three women were followed-up for a median of 62 months after surgery for Stage I-III breast cancer: The concentration of cathepsin D (CD) in tumor cytosols was compared to the standard prognostic factors for the disease and related to relapse free and overall survival and type of relapse. Three groups were identified with different prognostic profile. High CD levels significantly shorten DFS ill both node-negative and node-positive patients; a correlation between high cathepsin D levels and locoregional relapse should also be noted. This marker should be included in the initial evaluation of breast cancer as an indicator of invasiveness.

引用

页码：1405 / 1409

页数：5

共 50 条

[41] Immunoenzymatically determined pepsinogen C concentration in breast tumor cytosols:: An independent favorable prognostic factor in node-positive patients
Scorilas, A
Diamandis, EP
Levesque, MA
Papanastasiou-Diamandi, A
Khosravi, MJ
Giai, M
Ponzone, R
Roagna, R
Sismondi, P
López-Otin, C
CLINICAL CANCER RESEARCH, 1999, 5 (07) : 1778 - 1785
[42] 2-SITE IMMUNOENZYMOMETRIC ASSAY FOR THE 52-KDA CATHEPSIN-D IN CYTOSOLS OF BREAST-CANCER TISSUES
ROGIER, H
FREISS, G
BESSE, MG
CAVALIEBARTHEZ, G
GARCIA, M
PAU, B
ROCHEFORT, H
PAOLUCCI, F
CLINICAL CHEMISTRY, 1989, 35 (01) : 81 - 85
[43] TUMOR GRADE AS A PROGNOSTIC FACTOR IN PRIMARY BREAST-CANCER
CONTESSO, G
JOTTI, GS
BONADONNA, G
EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1989, 25 (03): : 403 - 409
[44] Low cathepsin D and low plasminogen activator type 1 inhibitor in tumor cytosols defines a group of node negative breast cancer patients with low risk of recurrence
Kute, TE
Grondahl-Hansen, J
Shao, SM
Long, R
Russell, G
Brünner, N
BREAST CANCER RESEARCH AND TREATMENT, 1998, 47 (01) : 9 - 16
[45] Low cathepsin D and low plasminogen activator type 1 inhibitor in tumor cytosols defines a group of node negative breast cancer patients with low risk of recurrence
Timothy Edward Kute
Jan Grøndahl-Hansen
Si-Ming Shao
Rena Long
Greg Russell
Nils Brünner
Breast Cancer Research and Treatment, 1998, 47 : 9 - 16
[46] CATHEPSIN D-CONCENTRATION AND CA-15-3-CONCENTRATION IN BREAST-CANCER CYTOSOL
CALLIES, R
KOSTNER, G
SCHEIT, S
EUROPEAN JOURNAL OF CANCER, 1990, 26 (02) : 178 - 178
[47] Concentration of Zinc, Selenium and Copper in Serum and Tumor Cytosols of Breast Cancer Patients: The Inhibitory Effect on Telomerase Gene Expression in Breast Cancer Cell Lines
Zarghami, N.
Asadi, J.
JOURNAL OF NUTRIGENETICS AND NUTRIGENOMICS, 2008, 1 (1-2) : 88 - 88
[48] EFFECT OF TUMOR SIZE ON THE ASSOCIATION BETWEEN PS2 AND CATHEPSIN-D IN PRIMARY BREAST-CANCER
MARSIGLIANTE, S
MOTTAGHI, A
MUSCELLA, A
CIARDO, V
LEO, G
STORELLI, C
INTERNATIONAL JOURNAL OF ONCOLOGY, 1995, 6 (01) : 69 - 73
[49] Prognostic value of cathepsin D in breast cancer: Comparison of immunohistochemical and immunoradiometric detection methods
Gohring, UJ
Scharl, A
Thelen, U
Ahr, A
Crombach, G
Titius, BR
JOURNAL OF CLINICAL PATHOLOGY, 1996, 49 (01) : 57 - 64
[50] Relationship between cathepsin-D and other prognostic factors in human breast cancer
Glikman, P
Rogozinski, A
Mosto, J
Pollina, A
Garbovesky, C
Levy, C
TUMORI JOURNAL, 1997, 83 (03): : 685 - 688

← 1 2 3 4 5 →